Abstract:BackgroundLeukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) is an immune inhibitory receptor that binds collagen-like domains commonly found in extracellular matrix (ECM) collagens and complement component C1q. LAIR-1 is expressed on several immune cell types including activated T cells, B cells, NK cells, dendritic cells, and macrophages. Numerous cancer types including gastric, colon, ovarian, bladder, and others, upregulate collagens which enhances tumor growth, metastases, and invasion while actively suppressing antitumor immunity. While a soluble decoy, LAIR-2, is expressed in humans and competes with LAIR-1 for binding of collagen domains, excess LAIR ligands in the tumor often result in an immune suppressive environment.MethodsHere, we report on a novel immunotherapy approach combining NC410, a novel fusion protein consisting of two LAIR-2 molecules grafted on to an IgG1 antibody backbone, capable of targeting the tumor ECM and blocking LAIR-1 signaling; and bintrafusp alfa, a first-in-class bifunctional fusion protein composed of the extracellular domain of the human transforming growth factor β receptor II (TGF-βRII or TGF-β ”trap”) fused via a flexible linker to the C-terminus of each heavy chain of an IgG1 antibody blocking programmed death ligand 1 (anti–PD-L1).ResultsWe have demonstrated that the combination of NC410 and bintrafusp alfa more effectively controls in vivo tumor growth of the collagen rich MC38 colon and EMT6 mammary carcinomas compared to either monotherapy. We demonstrate that this potent anti-tumor immune response is propagated through the synergy of activated tumor infiltrating lymphocytes and a repolarization of myeloid cells in the tumor microenvironment. MC38 tumors treated with the combination of NC410 plus bintrafusp alfa contained higher numbers of infiltrating T cells, NK cells, and M1 polarized macrophages.ConclusionsThis study highlights the synergy of reshaping the large suppressive myeloid cell populations often present in tumors with activation of adaptive T-cell immune responses dampened by checkpoint inhibition. The results also provide the rationale for the future evaluation of this combination therapy in the clinic.

Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex

Collagenase-Loaded H-TiO<sub>2</sub> Nanoparticles Enhance Ultrasound Imaging-Guided Sonodynamic Therapy in a Pancreatic Carcinoma Xenograft Model via Digesting Stromal Barriers

High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.

Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors

570 Blockade of the Inhibitory Collagen Receptor LAIR-1, PD-L1, and TGF-β Promotes Anti-Tumor Activity Through T Cell Activation and Myeloid Cell Polarization

Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors

Targeted antibody and cytokine cancer immunotherapies through collagen affinity

Collagen Hollow Spheres : An Effective System for Nucleic Acids Delivery

Injectable Corilagin/low Molecular Weight Chitosan/plga-Peg-plga Thermosensitive Hydrogels for Localized Cancer Therapy and Promoting Drug Infiltration by Modulation of Tumor Microenvironment

Intramuscular Electroporation Delivery of IFN-α Gene Therapy for Inhibition of Tumor Growth Located at a Distant Site

Evaluation of collagen and methylated collagen as gene carriers.

Localized Co-Delivery of Collagenase and Trastuzumab by Thermosensitive Hydrogels for Enhanced Antitumor Efficacy in Human Breast Xenograft.

Delivery of Interferon Β-Encoding Plasmid Via Lipid Nanoparticle Restores Interferon Β Expression to Enhance Antitumor Immunity in Colon Cancer.

Collagenase-Encapsulated Ph-Responsive Nanoscale Coordination Polymers for Tumor Microenvironment Modulation and Enhanced Photodynamic Nanomedicine

A Size-Changeable Collagenase-Modified Nanoscavenger for Increasing Penetration and Retention of Nanomedicine in Deep Tumor Tissue

Collagenase Nanocapsules: An Approach to Fibrosis Treatment

Targeted and Sustained Corelease of Chemotherapeutics and Gene by Injectable Supramolecular Hydrogel for Drug-Resistant Cancer Therapy.

Pluronic (R) L64-Mediated Stable Hif-1 Alpha Expression in Muscle for Therapeutic Angiogenesis in Mouse Hindlimb Ischemia

Tumor-Colonizing E. coli Expressing Both Collagenase and Hyaluronidase Enhances Therapeutic Efficacy of Gemcitabine in Pancreatic Cancer Models

Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues

Enhancing the tumor penetration of multiarm polymers by collagenase modification